CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CASI Pharmaceuticals's enterprise value was $15.62M on Oct 19, 2026, against $27.23M a year earlier. Over the last 5 years it ranged from -$23.55M to $99.41M, with a median of $20.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $15.62M | -13.7% |
| 2025 | Dec 31, 2025 | $18.09M | -34.6% |
| 2024 | Dec 31, 2024 | $27.66M | -42.1% |
| 2023 | Dec 29, 2023 | $47.78M | – |
| 2022 | Dec 30, 2022 | -$23.55M | -126.7% |
| 2021 | Dec 31, 2021 | $88.36M | – |
See a number that looks wrong?